UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy

Journal of Nuclear Medicine, 2008-11, Vol.49 (11), p.1884-1899

2008

Volltextzugriff (PDF)

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

Journal of clinical oncology, 2009-04, Vol.27 (12), p.2046-2051

2009

Volltextzugriff (PDF)

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Blood, 2004-07, Vol.104 (1), p.227-236

2004

Volltextzugriff (PDF)

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Clinical cancer research, 2000-02, Vol.6 (2), p.406

2000

Volltextzugriff (PDF)

Bone Marrow Dosimetry Using Blood-Based Models for Radiolabeled Antibody Therapy: A Multiinstitutional Comparison

The Journal of nuclear medicine (1978), 2004-10, Vol.45 (10), p.1725-1733

2004

Volltextzugriff (PDF)

Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry

The Journal of nuclear medicine (1978), 2000-05, Vol.41 (5), p.863-873

2000

Volltextzugriff (PDF)

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): Initial phase I/II study results

Cancer biotherapy & radiopharmaceuticals, 2000-02, Vol.15 (1), p.15-29

2000

Volltextzugriff (PDF)

Marrow Toxicity and Radiation Absorbed Dose Estimates from Rhenium-186-Labeled Monoclonal Antibody

The Journal of nuclear medicine (1978), 1998-10, Vol.39 (10), p.1746-1751

1998

Volltextzugriff (PDF)

Clinical aspects of radiation nephropathy

Cancer biotherapy & radiopharmaceuticals, 2004-06, Vol.19 (3), p.359-362

Breitz, Hazel

2004

Volltextzugriff (PDF)

Dosimetry model for radioactivity localized to intestinal mucosa

Cancer biotherapy & radiopharmaceuticals, 2004-06, Vol.19 (3), p.293-307

2004

Volltextzugriff (PDF)

Patient-Specific Dosimetry of Pretargeted Radioimmunotherapy Using CC49 Fusion Protein in Patients with Gastrointestinal Malignancies

The Journal of nuclear medicine (1978), 2005-04, Vol.46 (4), p.642

2005

Volltextzugriff (PDF)

Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy

Clinical nuclear medicine, 1997-09, Vol.22 (9), p.615-620

1997

Volltextzugriff (PDF)

Pretargeted radioimmunotherapy (PRIT™) for treatment of non-Hodgkin's lymphoma (NHL)

Critical reviews in oncology/hematology, 2001-10, Vol.40 (1), p.37-51

2001

Volltextzugriff (PDF)

PD6-1-1: A phase 2 study of picoplatin monotherapy for patients with small cell lung cancer (SCLC) who have resistant or refractory disease or have relapsed within 180 days of completing first-line, platinum-containing chemotherapy

Journal of thoracic oncology, 2007-08, Vol.2 (8), p.S428-S429

2007

Volltextzugriff (PDF)

Abstract B49: FOLPI (picoplatin/5-fluorouracil/leucovorin) versus modified FOLFOX-6 as a neuropathy-sparing first-line therapy for colorectal cancer (CRC)

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.B49-B49

2009

Volltextzugriff (PDF)

Dosimetry in a myeloablative setting

Cancer biotherapy & radiopharmaceuticals, 2002-02, Vol.17 (1), p.119-128

Breitz, Hazel

2002

Volltextzugriff (PDF)

Dosimetry in a myeloablative setting : The role and option for dosimetry in clinical pratice

Cancer biotherapy & radiopharmaceuticals, 2002, Vol.17 (1), p.119-128

BREITZ, Hazel

2002

Volltextzugriff (PDF)

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

Journal of clinical oncology, 2009, Vol.27 (12), p.2046-2051

2009

Volltextzugriff (PDF)

sup 166^Ho-DOTMP Radiation-Absorbed Dose Estimation for Skeletal Targeted Radiotherapy

The Journal of nuclear medicine (1978), 2006-03, Vol.47 (3), p.534

2006

Volltextzugriff (PDF)

How far have we come with solid (nonhematologic) tumor radioimmunotherapy?

The Journal of nuclear medicine (1978), 2000-12, Vol.41 (12), p.2011-2014

Breitz, H B

2000

Volltextzugriff (PDF)

Holmium-166 (166Ho)-DOTMP Skeletal Targeted Radiotherapy (STR™) with Melphalan and Autologous Peripheral Stem Cell Transplant (PBSCT) for Multiple Myeloma (MM)

Blood, 2004-11, Vol.104 (11), p.922-922

2004

Volltextzugriff (PDF)

Contribution to Red Marrow Absorbed Dose from Total Body Activity: A Correction to the MIRD Method

The Journal of nuclear medicine (1978), 2001-03, Vol.42 (3), p.492-498

2001

Volltextzugriff (PDF)

Impact of Holmium-DOTMP on Transplant Outcomes. Results of a Retrospective Single Institution Analysis

Blood, 2005-11, Vol.106 (11), p.426-426

2005

Volltextzugriff (PDF)

Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein

Cancer biotherapy & radiopharmaceuticals, 2005-08, Vol.20 (4), p.379-390

2005

Volltextzugriff (PDF)

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL) : Monoclonal antibodies and cancer

Critical reviews in oncology/hematology, 2001, Vol.40 (1), p.37-51

2001

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(51)
magazinearticle
(1)

Sprache

Englisch
(51)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Humans
(35)
Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Radiology, Nuclear Medicine & Medical Imaging
(22)
Female
(19)
Male
(19)
Biological And Medical Sciences
(17)
Medical Sciences
(17)
Middle Aged
(16)
Adult
(14)
Aged
(14)
Radioisotopes - Therapeutic Use
(14)
Radioimmunotherapy
(13)
Tissue Distribution
(11)
Radioimmunotherapy - Methods
(10)
Oncology
(9)
Radioisotopes - Pharmacokinetics
(9)
Dosimetry
(8)
Radiopharmaceuticals - Pharmacokinetics
(8)
Rhenium - Therapeutic Use
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

MIRD Pamphlet No. 20: The Effect of Model Assumptions on Kidney Dosimetry and Response--Implications for Radionuclide Therapy

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

Phase 1 trial of a novel anti-CD20 fusion protein in pretargeted radioimmunotherapy for B-cell non-Hodgkin lymphoma

Phase II Trial of Yttrium-90-DOTA-Biotin Pretargeted by NR-LU-10 Antibody/Streptavidin in Patients with Metastatic Colon Cancer

Bone Marrow Dosimetry Using Blood-Based Models for Radiolabeled Antibody Therapy: A Multiinstitutional Comparison

Breast Milk Excretion of Radiopharmaceuticals: Mechanisms, Findings, and Radiation Dosimetry

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL): Initial phase I/II study results

Marrow Toxicity and Radiation Absorbed Dose Estimates from Rhenium-186-Labeled Monoclonal Antibody

Clinical aspects of radiation nephropathy

Dosimetry model for radioactivity localized to intestinal mucosa

Patient-Specific Dosimetry of Pretargeted Radioimmunotherapy Using CC49 Fusion Protein in Patients with Gastrointestinal Malignancies

Clinical experience with Tc-99m nofetumomab merpentan (Verluma) radioimmunoscintigraphy

Pretargeted radioimmunotherapy (PRIT™) for treatment of non-Hodgkin's lymphoma (NHL)

PD6-1-1: A phase 2 study of picoplatin monotherapy for patients with small cell lung cancer (SCLC) who have resistant or refractory disease or have relapsed within 180 days of completing first-line, platinum-containing chemotherapy

Abstract B49: FOLPI (picoplatin/5-fluorouracil/leucovorin) versus modified FOLFOX-6 as a neuropathy-sparing first-line therapy for colorectal cancer (CRC)

Dosimetry in a myeloablative setting

Dosimetry in a myeloablative setting : The role and option for dosimetry in clinical pratice

Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer

sup 166^Ho-DOTMP Radiation-Absorbed Dose Estimation for Skeletal Targeted Radiotherapy

How far have we come with solid (nonhematologic) tumor radioimmunotherapy?

Holmium-166 (166Ho)-DOTMP Skeletal Targeted Radiotherapy (STR™) with Melphalan and Autologous Peripheral Stem Cell Transplant (PBSCT) for Multiple Myeloma (MM)

Contribution to Red Marrow Absorbed Dose from Total Body Activity: A Correction to the MIRD Method

Impact of Holmium-DOTMP on Transplant Outcomes. Results of a Retrospective Single Institution Analysis

Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein

Pretargeted radioimmunotherapy (PRIT) for treatment of non-Hodgkin's lymphoma (NHL) : Monoclonal antibodies and cancer

Suchergebnisse filtern